Affimed Gmbh

Rvt Process Equipment Gmbh

Affimed Therapeutics, Ag

Schering Aktiengesellschaft

Karin Hoffmann

Melvyn Little

Uwe Reusch

Stefan Knackmuss

Fabrice Le Gall

Sergey Kipriyanov

Werner Geipel

Peter Röttgen

Patrick Franke

Vera Mick

Christian Geipel

Christian Mehringer

Sergej Kiprijanov

Stefan Hans Knackmuss

Stefan H J Knackmuss

Stefan Weiss

The present disclosure relates to a packing element, in particular for mass and/or heat exchange columns, through which at least one gas and/or at least one liquid flow flows, comprising a plurality of neighbouring strips curved inwards and/or outwards, wherein each strip is connected to the neighbouring strips at at least one end thereof. It is the object of the present invention to provide a packing element that is improved relative to the state of the art. According to the disclosure, this object is achieved in that at least one of the strips has an irregular shape.

Packing element having strips with asymmetrical arch or wave shapes

The present invention relates to binding molecules that specifically bind to the human Fc gamma receptor expressed on the surface of natural killer (NK) cells and macrophages (i.e. Fc&#x3b3;RIIIA), and in particular binding molecules that specifically bind the A form Fc&#x3b3;RIII but do not bind to the B form of Fc&#x3b3;RIII, as well as to the use of such binding molecules in the diagnosis and treatment of disease. The invention further extends to polynucleotides encoding such binding molecules, host cells comprising such polynucleotides and methods of producing binding molecules of the invention using such host cells.

Anti-CD16 binding molecules

Described is the use of a recombinant antibody comprising a binding site specific for an epitope of the laminin receptor or laminin receptor precursor for the treatment or diagnosis of various cancers, particularly B-CLL. Preferably, this antibody additionally comprises a binding site for at least one particular cell surface antigen.

Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types

Growing community of inventors

Schwetzingen, Germany

Karin Hoffmann